Healthcare providers: START HERE

Big Changes to Medicare Part D in 2025: What You Need to Know

Written by: Daniel Trecroci

1 minute read

November 21, 2024

Eli Lilly helps patients and caregivers navigate key Medicare Part D changes for 2025, including $2,000 caps, payment plans, and expanded aid

Eli Lilly and Company is helping patients and caregivers understand important changes to Medicare Part D—set to begin in 2025.

To help explain the changes, Lilly field teams will provide brochures to doctors’ offices that can help easily explain the changes to patients and their caregivers

What is Medicare Part D?

Medicare Part D helps seniors pay for prescription medicines.

In 2025, three major changes aim to make medications more affordable and accessible.

What Are the Three Key Updates to Medicare Part D?

$2,000 Out-of-Pocket Maximum

  • Starting in 2025, Part D enrollees won’t pay more than $2,000 annually for prescription drugs.
  • After reaching this limit, no further costs apply for the rest of the year.’
  • This replaces the current $3,300 cap in 2024 and eliminates the coverage gap phase.

Monthly Payment Plan

  • The Medicare Prescription Payment Plan (M3P) lets you spread out costs into manageable monthly payments.
  • Sign up during Fall Open Enrollment (ends December 7, 2024) or through your drug plan later.

Expanded Extra Help Program

  • More people qualify for the Extra Help subsidy, which lowers drug costs for low-income individuals.
  • In 2024, individuals earning $22,590 or less and married couples earning $30,660 or less may qualify.
  • Benefits include lower premiums, no deductibles, and reduced or no copays.

Appealing a Denied Medicine

If your drug is denied, you can appeal.

Standard appeals take 72 hours, while urgent cases are decided within 24 hours.

Key Dates

Open enrollment: Through December 7, 2024.
Updates take effect: January 1, 2025.

For questions, talk to your drug plan or visit Medicare.gov.

These updates are designed to make managing medications simpler and more affordable for everyone.

Author

Daniel Trecroci

Daniel Trecroci has been writing about diabetes for over 20 years. As one of the original team members at Diabetes Health, he spent more than a decade as Managing Editor, publishing thousands of articles and helping to establish the outlet as a leading resource for people living with diabetes. He later served as Content Manager for OneTouchGold, Johnson & Johnson/LifeScan’s official digital publication. Under his leadership, OneTouchGold earned the Web Marketing Association’s award for “Best Health & Wellness” website. Daniel has also written for Diabetes Research Institute, dLife, diaTribe, Healthline, CareDx, Pendulum Therapeutics, and Hero Bread.